AKT1 and acute myeloid leukemia: This double shuttling of Foxo3a is observed in AML-AF9 leukemia, where leukemia-initiating cells (LICs) have the GMP phenotype but, unlike the bulk tumor cells, display an attenuated pattern of AKT activation.